PGP and acute myeloid leukemia: Among the 31 AML samples evaluated, significant P-gp activity was found in 7 of 31 (23%); zosuquidar enhanced drug cytotoxicity in 5 of these 7 (71%), all of which were older patients > 60 years of age.